• Research1
  • Research2
  • Research3

Research Projects

S.No

Project Title

Duration

Funding agency

Amount

2017-18

1

Binding kinetic and structural implications in inhibition of sHER2 d-III & d-II in association with Pertzumumab structural study

2015-18

SERB

24,18,000

2

Structural insights to inhibit Epidermal Growth Factor Receptor (EGFR) dimerization & activation: Panitumumab induced Conformational study

2014-17

DBT

23,75,420

3

Effect of O-Sialylation on Epidermal Growth factor receptor (EGFR) mediated homo/hetero dimerization (EGFR/HER2) and activation in lung cancer cells

2017-20

DHR

31,00,000

4

Nitric oxide donating acridones as inhibitors of doxorubicin efflux in cancer cells and their membrane perturbing studies

2017-20

ICMR, Sanctioned

20,50,000

2016-17

5

Role of individual isoforms of Phosphoinositide 3-kinase (PI3K) inhibitors and non-selective inhibitors in in vivo models of Alzheimer's disease (AD).

2014-17

DST

8,00,000

6

Structural insights to inhibit Epidermal Growth Factor Receptor (EGFR) dimerization & activation: Panitumumab induced Conformational study

2014-17

DBT

11,50,000

7

Optimization and evaluation of prazosin floating microspheres using response surface methodology

2014-17

DST

7,20,000

8

Formulation evaluation and optimization of floating drug delidery system of antihypertensive drugs.

2014-17

DST

8,20,000

9

Neuroprotective activity of polyherbal formulation aganist transient global ischemia induced brain damage in normal and alloxan induced diabetic rats

2014-17

DST

8,10,000

2015-16

10

Structural insights to inhibit Epidermal Growth Factor Receptor (EGFR)   Dimerization & Activation: Panitumumab induced conformational study.

2014-17

DBT

16,65,480

11

Role of individual isoforms of Phosphoinositide 3-kinase (PI3K) inhibitors and non-selective inhibitors in in vivo models of Alzheimer's disease (AD).

2014-17

DST

14,50,000

12

Design and synthesis of quinoline tagged acridones as reverters of multidrug resistance (MDR) in cancer

2012-15

AICTE

3,00,000

13

Design and Synthesis of Nitric Oxide Donating Phenoxazine Derivatives as Reverters of Multidrug Resistance (MDR) in Cancer cells

2012-15

SERB

4,50,000

14

Optimization and evaluation of prazosin floating microspheres using response surface methodology

2014-17

DST

7,00,000

15

Formulation evaluation and optimization of floating drug delidery system of antihypertensive drugs.

2014-17

DST

5,00,000

16

Neuroprotective activity of polyherbal formulation aganist transient global ischemia induced brain damage in normal and alloxan induced diabetic rats

2014-17

DST

8,10,000

17

Projects under Institute - Industry Innovation Cell (IIIC)

2013-15

MSME

1,25000